MYELODYSPLASTIC SYNDROME side effect
What is MYELODYSPLASTIC SYNDROME ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
MYELODYSPLASTIC SYNDROME and Recently Reported Side Effects
MYELODYSPLASTIC SYNDROME and 15 most Active Side Effect polls
MYELODYSPLASTIC SYNDROME and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with MYELODYSPLASTIC SYNDROME
ABATACEPT ACTOS ALEMTUZUMAB ALKERAN ALTACE AMBISOME AMLODIPINE AMOXICILLIN ARANESP ARAVA ARIMIDEX AVANDIA AVONEX AZATHIOPRINE BELATACEPT BETAFERON BETASERON BEXXAR BRIPLATIN BUSULFEX BYETTA CAMPATH CARBOPLATIN CARMUSTINE CASODEX CELEBREX CILOSTAZOL CIPROFLOXACIN CISPLATIN CITALOPRAM CLOZAPINE COMTAN CONGESCOR COREG CYCLOPHOSPHAMIDE CYTARABINE CYTOXAN DACOGEN DANTROLENE DAUNORUBICIN DESLORATADINE DEXAMETHASONE DIGOXIN DULOXETINE ENBREL ENDOXAN EPIRUBICIN ETOPOSIDE EUGLUCON EXJADE FILGRASTIM FLUDARA FLUOROURACIL FOLIC FORADIL FORTEO GEFITINIB GEMCITABINE GLEEVEC GLIVEC HEPARIN HERCEPTIN HUMATROPE HUMIRA HYDROCHLOROTHIAZ HYDRODIURIL HYDROXYCHLOROQUI IBANDRONIC IDARUBICIN IMATINIB INCRELEX INTERFERON ISCOVER KEPPRA LAMICTAL LAMIVUDINE LIPITOR MABTHERA MANIDIPINE MELPHALAN METHOTREXATE MITOMYCIN NEUPOGEN NORVASC OMEPRAZOLE PARAPLATIN PEMETREXED PRANDIN PREDNISONE PROCRIT PROGRAF RANIBIZUMAB REBIF REMICADE REVLIMID RIBAVIRIN RITUXAN RITUXIMAB ROSIGLITAZONE ROSUVASTATIN TAXOL TEMODAL THALOMID THYMOGLOBULIN TOSITUMOMAB TRETINOIN VALPROIC VELCADE VFEND VINCRISTINE ZEFIX ZEVALINLipitor Side Effects Report #5647601-0
Physician from JAPAN reported LIPITOR problem on Feb 25, 2008. Male patient, 73 years of age, was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . LIPITOR dosage: DAILY DOSE:5MG. During the same period patient was treated with ASPIRIN, NU LOTAN, ALLOPURINOL, MEXITIL, JUVELA, COMELIAN, TERNELIN, CINAL. Patient recovered.
Rituxan Side Effects Report #5650985-0
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 25, 2008. Female patient, 71 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
Rituxan Side Effects Report #5651005-4
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 25, 2008. Male patient, 56 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
Rituxan Side Effects Report #5651006-6
RITUXAN problem was reported by a Physician from UNITED KINGDOM on Feb 25, 2008. Male patient, 42 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
Interferon Side Effects Report #5651221-1
Physician from UNITED STATES reported INTERFERON ALFA problem on Feb 11, 2008. Female patient, 45 years of age, was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with RITUXIMAB, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN. Patient died.
Rituxan Side Effects Report #5651484-2
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 25, 2008. Female patient, 58 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/KG, 1/MONTH. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, INTRON A. Patient died.
Rituxan Side Effects Report #5651495-7
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 25, 2008. Female patient, 49 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
Rituxan Side Effects Report #5651499-4
RITUXAN problem was reported by a Physician from UNITED STATES on Feb 25, 2008. Female patient, 45 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
Enbrel Side Effects Report #5652981-6
Physician from GERMANY reported ENBREL problem on Feb 25, 2008. Female patient, weighting 54.45 lb, was diagnosed with juvenile arthritis, polyarthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, pancytopenia, . ENBREL dosage: unknown. During the same period patient was treated with IMUREK, METHOTREXATE, BELOC ZOK, ESIDRIX, NORDITROPIN, INDOMETHACIN. Patient was hospitalized. Patient recovered.
Carmustine Side Effects Report #5660861-5
CARMUSTINE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2007. Male patient, 42 years of age, was diagnosed with astrocytoma and was treated with CARMUSTINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . CARMUSTINE dosage: unknown. Patient recovered.
Comtan Side Effects Report #5662951-X
Physician from JAPAN reported COMTAN problem on Feb 28, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with COMTAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, white blood cell count decreased, . COMTAN dosage: 300 MG/DAY. During the same period patient was treated with LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.
Comtan Side Effects Report #5663994-2
COMTAN problem was reported by a Physician from JAPAN on Feb 28, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with COMTAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, white blood cell count decreased, . COMTAN dosage: 300 MG/DAY. During the same period patient was treated with LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.
Alemtuzumab Side Effects Report #5669134-8
Physician from UNITED STATES reported ALEMTUZUMAB problem on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ALEMTUZUMAB dosage: unknown. Patient recovered.
Alemtuzumab Side Effects Report #5670250-5
ALEMTUZUMAB problem was reported by a Physician from UNITED STATES on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ALEMTUZUMAB dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5671703-6
Physician from UNITED STATES reported REVLIMID problem on Mar 10, 2008. Female patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/30/2007.
Comtan Side Effects Report #5688224-7
COMTAN problem was reported by a Physician from JAPAN on Mar 10, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with COMTAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . COMTAN dosage: 300 MG. During the same period patient was treated with LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.
Exjade Side Effects Report #5621803-1
Consumer or non-health professional from UNITED STATES reported EXJADE problem on Feb 04, 2008. Male patient, 88 years of age, was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . EXJADE dosage: 1500MG QD. Patient died.
Omeprazole Side Effects Report #5623066-X
OMEPRAZOLE problem was reported by a Health Professional from NEW ZEALAND on Feb 11, 2008. Female patient, 76 years of age, was diagnosed with oesophagitis, essential hypertension and was treated with OMEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . OMEPRAZOLE dosage: unknown. During the same period patient was treated with CANDESARTAN, CIPROFLOXACIN, ACYCLOVIR, FLUCONAZOLE. Patient recovered.
Lipitor Side Effects Report #5635265-1
Physician from JAPAN reported LIPITOR problem on Feb 14, 2008. Male patient, 73 years of age, was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . LIPITOR dosage: unknown. During the same period patient was treated with ASPIRIN, NU LOTAN, ALLOPURINOL, MEXITIL, JUVELA, COMELIAN, TERNELIN, CINAL. Patient recovered.
Rituxan Side Effects Report #5635516-3
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient, 71 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
Interferon Side Effects Report #5637329-5
Physician from UNITED STATES reported INTERFERON ALFA problem on Feb 11, 2008. Male patient, 56 years of age, was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with RITUXIMAB, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
Interferon Side Effects Report #5637332-5
INTERFERON ALFA problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient, 45 years of age, was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with RITUXIMAB, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN. Patient recovered.
Rituxan Side Effects Report #5637690-1
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 11, 2008. Female patient, 58 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/KG, 1/MONTH. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, INTRON A. Patient died.
Rituxan Side Effects Report #5637691-3
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient, 49 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
Rituxan Side Effects Report #5639590-X
Physician from UNITED STATES reported RITUXAN problem on Feb 11, 2008. Female patient, 45 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient recovered.
Rituxan Side Effects Report #5639591-1
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Male patient, 56 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
Rituxan Side Effects Report #5639603-5
Physician from UNITED KINGDOM reported RITUXAN problem on Feb 11, 2008. Male patient, 42 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
Valproic Side Effects Report #5589006-7
VALPROIC ACID problem was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2008. Female patient, 63 years of age, was diagnosed with convulsion and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . VALPROIC ACID dosage: unknown. During the same period patient was treated with NEURONTIN. Patient recovered.
Betaseron Side Effects Report #5593066-7
Health Professional from SWEDEN reported BETASERON problem on Jan 11, 2008. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . BETASERON dosage: unknown. During the same period patient was treated with SELOKEN ZOC, DETRUSITOL, ENALAPRIL MALEATE, SIMVASTATIN, FURADANTIN, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5643981-0
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Dec 21, 2007. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . REVLIMID dosage: 5 MG,1 IN 1 D, ORAL. Patient died on 12/04/2007.
Pemetrexed Side Effects Report #5535863-X
Physician from CANADA reported PEMETREXED problem on Nov 23, 2007. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, myeloid leukaemia, . PEMETREXED dosage: 765 MG, UNK. During the same period patient was treated with CISPLATIN. Patient died on 10/22/2007.
Fluorouracil Side Effects Report #5543341-7
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2007. Male patient, 74 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . FLUOROURACIL dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOMYCIN, PROLEUKIN, EPIRUBICIN, METHOTREXATE, LEUCOVORIN CALCIUM. Patient recovered.
Rosuvastatin Side Effects Report #5564363-6
Physician from ARGENTINA reported ROSUVASTATIN problem on Dec 11, 2007. Male patient, weighting 216.1 lb, was diagnosed with cardiovascular event prophylaxis, hypertension and was treated with ROSUVASTATIN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ROSUVASTATIN dosage: unknown. During the same period patient was treated with TERLOC DUO, HYGROTON, ASPIRIN. Patient recovered.
Actos Side Effects Report #5580212-4
ACTOS problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 19, 2007. Male patient, 78 years of age, was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ACTOS dosage: unknown. During the same period patient was treated with CANDESARTAN, ATORVASTATIN CALCIUM, BENDROFLUMETHIAZIDE. Patient recovered.
Taxol Side Effects Report #5505184-X
Health Professional from JAPAN reported TAXOL problem on Oct 31, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . TAXOL dosage: unknown. Patient recovered.
Taxol Side Effects Report #5508624-5
TAXOL problem was reported by a Health Professional from JAPAN on Nov 06, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . TAXOL dosage: unknown. During the same period patient was treated with TAXOTERE, TAMOXIFEN CITRATE, TOREMIFENE, ANASTROZOLE, DI INCADRONATE, MEDROXYPROGESTERONE ACETATE, CAPECITABINE, CYCLOPHOSPHAMIDE. Patient recovered.
Cilostazol Side Effects Report #5512868-6
Consumer or non-health professional from JAPAN reported CILOSTAZOL problem on Oct 19, 2007. Female patient was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . CILOSTAZOL dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient recovered.
Prednisone Side Effects Report #5521467-1
PREDNISONE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2007. Male patient, 50 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . PREDNISONE dosage: unknown. During the same period patient was treated with DOXORUBICIN, CARBOPLATIN, ETOPOSIDE, VINCRISTINE, CYCLOPHOSPHAMIDE, IFOSFAMIDE, RITUXIMAB. Patient recovered.
Gemcitabine Side Effects Report #5522347-8
Physician from JAPAN reported GEMCITABINE problem on Nov 08, 2007. Male patient, weighting 102.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . GEMCITABINE dosage: 900 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
Gemcitabine Side Effects Report #5522350-8
GEMCITABINE problem was reported by a Physician from JAPAN on Nov 08, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . GEMCITABINE dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient recovered.
Endoxan Side Effects Report #5523205-5
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Nov 09, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver, breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ENDOXAN dosage: unknown. During the same period patient was treated with PACLITAXEL, DOCETAXEL, CAPECITABINE, TAMOXIFEN CITRATE, TOREMIFENE CITRATE, ANASTROZOLE, DI INCADRONATE. Patient recovered.
Taxol Side Effects Report #5526213-3
TAXOL problem was reported by a Health Professional from JAPAN on Nov 22, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver, breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . TAXOL dosage: unknown. During the same period patient was treated with ENDOXAN, DOCETAXEL, CAPECITABINE, TAXOTERE, TAMOXIFEN CITRATE, TOREMIFENE, ANASTROZOLE. Patient recovered.
Belatacept Side Effects Report #5526805-1
Consumer or non-health professional from ARGENTINA reported BELATACEPT problem on Nov 20, 2007. Female patient, 37 years of age, was diagnosed with renal transplant and was treated with BELATACEPT. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . BELATACEPT dosage: unknown. During the same period patient was treated with CELLCEPT, PREDNISONE. Patient was hospitalized. Patient recovered.
Rituximab Side Effects Report #5527060-9
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Nov 14, 2007. Female patient, weighting 132.1 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, pyrexia, sepsis, . RITUXIMAB dosage: 800 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Celebrex Side Effects Report #5528157-X
Physician from FRANCE reported CELEBREX problem on Nov 19, 2007. Male patient, weighting 174.2 lb, was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . CELEBREX dosage: unknown. During the same period patient was treated with AMLOR, COKENZEN, MISOPROSTOL. Patient was hospitalized. Patient recovered.
Actos Side Effects Report #5531361-8
ACTOS problem was reported by a Consumer or non-health professional from JAPAN on Nov 16, 2007. Male patient, 66 years of age, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ACTOS dosage: 15 MG (15 MG, 1 D) PER ORAL. During the same period patient was treated with PANALDINE, BAYMYCARD, ULGUT, ISOSORBIDE MONONITRATE, GLIMICRON, RIZE, SERMION. Patient recovered.
Actos Side Effects Report #5533920-5
Consumer or non-health professional from JAPAN reported ACTOS problem on Nov 21, 2007. Male patient, 65 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ACTOS dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL; 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with BAYMYCARD, ULGUT, ISOSORBIDE MONONITRATE, GLIMICRON, RIZE, SERMION, SIGMART. Patient recovered.
Belatacept Side Effects Report #5475889-8
BELATACEPT problem was reported by a Consumer or non-health professional from ARGENTINA on Sept 27, 2007. Female patient, 37 years of age, was diagnosed with renal transplant and was treated with BELATACEPT. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . BELATACEPT dosage: unknown. During the same period patient was treated with CELLCEPT, PREDNISONE. Patient was hospitalized. Patient recovered.
Enbrel Side Effects Report #5478127-5
Physician from JAPAN reported ENBREL problem on Sept 25, 2007. Male patient, 61 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ENBREL dosage: unknown. Patient was hospitalized. Patient recovered.
Epirubicin Side Effects Report #5484951-5
EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2007. Male patient, 74 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, no therapeutic response, rash pruritic, . EPIRUBICIN dosage: unknown. During the same period patient was treated with METHOTREXATE, MITOMYCIN, ETOPOSIDE, FLUOROURACIL, PROLEUKIN, LEUCOVORIN. Patient recovered.
Revlimid Side Effects Report #5489241-2
Physician from UNITED STATES reported REVLIMID problem on Oct 10, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma, myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, white blood cell count decreased, . REVLIMID dosage: 25 MG, DAILY, ORAL; 10 MG, DAILY X 28 DAYS, ORAL. During the same period patient was treated with EPOGEN. Patient recovered.